This PhD project at the Institute of Cancer Research focuses on understanding the evolution of resistance to cancer therapies, a major challenge in oncology. Drug resistance enables cancer cells to survive treatment, but often results in a proliferative cost, slowing down cell division. The research aims to investigate the mechanisms by which cancer cells adapt to therapeutic pressures and the biological consequences of resistance, with the goal of informing future strategies to overcome or prevent resistance in clinical settings.

The project is ideal for candidates interested in cancer biology, cellular adaptation, and therapeutic resistance. Details about funding, eligibility, and application procedures are not provided in the current description.